Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$555M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$435M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$428M |
| 4 |
Accenture
ACN
|
+$402M |
| 5 |
Fortive
FTV
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$535M |
| 2 |
NVIDIA
NVDA
|
+$518M |
| 3 |
Coca-Cola
KO
|
+$488M |
| 4 |
AT&T
T
|
+$474M |
| 5 |
Meta Platforms (Facebook)
META
|
+$461M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.74% |
| 2 | Healthcare | 2.42% |
| 3 | Financials | 2.31% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5076
ProShares UltraPro Russell2000
URTY
$364M
| $2.98M | ﹤0.01% |
39,628
-6,806
| -15% | -$518K |
|
5077
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.44B
| $2.98M | ﹤0.01% |
42,273
-10,612
| -20% | -$742K |
|
5078
PUT
LendingTree
TREE
$458M
| $2.98M | ﹤0.01% |
24,900
-4,200
| -14% | -$497K |
|
|
LOGC
5079
DELISTED
ContextLogic
LOGC
| $2.98M | ﹤0.01% |
44,134
-19,311
| -30% | -$1.36M |
|
|
SVNA
5080
DELISTED
7 Acquisition Corp
SVNA
| $2.98M | ﹤0.01% |
300,000
+60,000
| +25% | +$593K |
|
5081
CALL
iShares S&P GSCI Commodity-Indexed Trust
GSG
$940M
| $2.98M | ﹤0.01% |
131,500
+95,300
| +263% | +$1.96M |
|
5082
Mirion Technologies
MIR
$3.96B
| $2.98M | ﹤0.01% |
368,946
+262,497
| +247% | +$2.26M |
|
5083
PUT
Newmark Group
NMRK
$2.76B
| $2.98M | ﹤0.01% |
187,000
+48,300
| +35% | +$787K |
|
5084
MGP Ingredients
MGPI
$379M
| $2.98M | ﹤0.01% |
34,771
+18,259
| +111% | +$1.47M |
|
|
SGMO
5085
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.98M | ﹤0.01% |
512,208
-149,208
| -23% | -$887K |
|
|
SAGE
5086
PUT
DELISTED
Sage Therapeutics
SAGE
| $2.97M | ﹤0.01% |
89,800
-10,000
| -10% | -$376K |
|
|
CEQP
5087
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.97M | ﹤0.01% |
99,321
-4,213
| -4% | -$124K |
|
5088
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$549M
| $2.97M | ﹤0.01% |
+40,116
| New | +$2.95M |
|
5089
First Trust Emerging Markets AlphaDEX Fund
FEM
$795M
| $2.97M | ﹤0.01% |
118,114
-14,696
| -11% | -$379K |
|
5090
Nurix Therapeutics
NRIX
$2.81B
| $2.97M | ﹤0.01% |
211,783
+158,504
| +297% | +$2.81M |
|
5091
CALL
Astrana Health
ASTH
$2.02B
| $2.97M | ﹤0.01% |
61,200
-17,300
| -22% | -$892K |
|
5092
PIMCO Broad US TIPS Index Exchange-Traded Fund
TIPZ
$88.3M
| $2.96M | ﹤0.01% |
46,837
+42,029
| +874% | +$2.69M |
|
|
AMK
5093
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $2.96M | ﹤0.01% |
133,208
-86,431
| -39% | -$2.04M |
|
5094
PUT
Paylocity
PCTY
$7.87B
| $2.96M | ﹤0.01% |
14,400
-4,200
| -23% | -$850K |
|
|
ISBC
5095
DELISTED
Investors Bancorp, Inc.
ISBC
| $2.96M | ﹤0.01% |
198,247
+124,839
| +170% | +$2.04M |
|
|
CEQP
5096
PUT
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.96M | ﹤0.01% |
98,850
-49,150
| -33% | -$1.44M |
|
5097
Sabesp
SBS
$16.2B
| $2.96M | ﹤0.01% |
1,551,350
-733,417
| -32% | -$1.08M |
|
5098
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.38B
| $2.96M | ﹤0.01% |
35,284
+4,076
| +13% | +$335K |
|
|
GPP
5099
CALL
DELISTED
Green Plains Partners LP
GPP
| $2.96M | ﹤0.01% |
208,700
+88,700
| +74% | +$1.26M |
|
5100
TIM SA
TIMB
$8.29B
| $2.95M | ﹤0.01% |
203,759
+171,435
| +530% | +$2.16M |
|
Similar funds
Ken Griffin's Q1 2022 Portfolio in Review
As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.
- Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
- Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
- Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
- Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
- Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
- Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.